Background. The basic mechanism of delayed cerebral vasospasm following sub
arachnoid haemorrhage (SAH) has been intensively investigated. II is though
t that nitric oxide (NO) is a basic mediator of the cerebral vasodilator me
chanism. Previous clinical and experimental studies have shown a cerebral v
asodilator effect of high cervical spinal cord stimulation (SCS) however, t
he mechanism of this effect is still controversial. We investigated the con
tribution of the vasodilator effect of NO to this mechanism in an experimen
tal SAH model using rabbits.
Method. Four experimental groups, were designated: Group 1. Cerebral blood
flow (CBF) was evaluated by transcranial Doppler ultrasonography (TDU) in 8
rabbits. Group 2. In 4 animals, intracisternal saline injection and cervic
al epidural electrode placement without SCS were performed before TDU. Grou
p 3. TDU was performed before and after SCS on the fourth day of SAH in 8 r
abbits. Group 4. In 8 animals, N-Nitro-L-Arginine Methyl Esther (L-NAME) wa
s administered intracisternally on the fourth day of SAH, at a dose of 0.6
mg/kg, 45 minutes before SCS. CBF parameters, obtained via measurements or
calculations from TDU data, were compared.
Findings. The occurrence of vasospasm after SAH was demonstrated with signi
ficant changes in TDU parameters (high peak systolic velocity and positive
values of the degree of stenosis). In all SAH animals, SCS resulted in sign
ificant vasodilation. Even after the injection of L-NAME, SCS still had a s
ignificant vasodilatory effect in SAH animals, but there was also a signifi
cant difference in CBF parameters in the SCS-only group when compared with
the L-NAME treatment before SCS group.
Interpretation. The mechanism of the cerebral vasodilatory effect of SCS re
mains controversial. Our results revealed the contribution of a neurohumora
l effect which can be partially prevented by use of an NO synthase inhibito
r.